Two new trials saw no impact of thrombolytics in reducing disability at 90 days, but some positive signals offer hope.
This month: texts fail to up adherence, unstable AF risks, survival win for SGLT2 therapy in real-world HFrEF patients, and ...
An app-based program failed to boost function for most at 3 months, but positive signs were seen in women and after CABG.
The agency says the strategy would help millions quit and prevent 4.3 million tobacco-related deaths by the end of the ...
Iulia Iatan talks to C. Michael Gibson about how a low-carbohydrate, high-protein diet can increase plasma lipid levels and cardiovascular risk.
The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.
The two-tiered classification focuses on preclinical and clinical stages of disease, and should help inform treatment ...
The aim is to make it easier for consumers to determine how much saturated fat, sodium, and added sugar are inside.
On Monday, the Centers for Medicare & Medicaid Services (CMS) initiated a national coverage analysis of renal denervation for the treatment of uncontrolled hypertension.
The findings represent the first step to potentially augmenting current risk models with Lp(a) measurements, the author says.
The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.
Greater transparency, monitoring, and regulatory oversight are needed around these transactions, a researcher says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback